Caco-2 RAW-264.7 Co-Culture Model for Intestinal Inflammation Study

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack an effective in vitro model to study the absorption and inflammatory response of cyanidin-3-glucoside nanoliposomes by intestinal epithelial Caco-2 cells and macrophage RAW-264.7 cells, which is crucial for understanding their absorption mechanism and therapeutic potential.

Innovation Solution

A co-culture model is established using Caco-2/RAW-264.7 cells induced by lipopolysaccharides, where Caco-2 cells are cultured on a Transwell plate and RAW-264.7 cells are on the other side, with lipopolysaccharides inducing an intestinal inflammatory response, allowing for the study of the absorption mechanism of cyanidin-3-glucoside nanoliposomes and their inflammatory effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a co-culture model is built to study absorption mechanism and inflammatory response, then the understanding of therapeutic potential is improved, but the device complexity and experimental setup become more complex

Engineering Contradiction:
Improveunderstanding of absorption mechanism and therapeutic potentialVSAvoidco-culture model setup
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The model segments the intestinal barrier system into two distinct cell types: Caco-2 cells forming the epithelial monolayer and RAW-264.7 macrophages in the submucosal layer. This segmentation allows independent study of absorption and inflammatory response while maintaining their physiological relationship through the Transwell structure.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The Transwell plate serves as an intermediary structure that physically separates yet functionally connects the two cell types. It enables the study of intercellular interactions and signal transmission while maintaining distinct microenvironments for each cell population.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If lipopolysaccharides are used to induce intestinal inflammatory response, then the study of macrophage-mediated absorption is enabled, but the complexity of establishing the inflammatory model increases

Engineering Contradiction:
Improvestudy of macrophage-mediated absorption mechanismVSAvoidinflammatory model establishment
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

RAW-264.7 macrophages are pre-cultured and differentiated before being combined with Caco-2 cells. This preliminary preparation ensures that the macrophages are in the appropriate functional state to respond to lipopolysaccharide stimulation and mediate the inflammatory response.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The model utilizes controlled changes in lipopolysaccharide concentration and exposure time to induce varying degrees of inflammatory response. This allows systematic study of macrophage activation and its impact on absorption mechanisms under different inflammatory conditions.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20240027428A1Method for building co-culture model for caco-2/raw-264.7 cells induced by lipopolysaccharides and application of co-culture model
Publication Date: 2024.01.25 ZHEJIANG UNIV OF TECH
  • US20240027428A1 patent drawing
  • US20240027428A1 patent drawing
  • US20240027428A1 patent drawing

AI summary

The present invention discloses a method for building a co-culture model for Caco-2/RAW-264.7 cells induced by lipopolysaccharides and an application of the co-culture model. The method includes: 1) culturing Caco-2 cells and RAW-264.7 cells; 2) inoculating the 5 Caco-2 cells onto an AP side of an upper chamber of a Transwell plate, and incubating; 3) inoculating the RAW-264.7 cells onto a 24-well plate, and incubating; 4) transferring the upper chamber of the Transwell plate into the 24-well plate; 5) dissolving lipopolysaccharides in PBS to prepare a stock solution, filtering, and diluting for later use; and 6) adding an LPS-10% DMEM medium on a BL side, incubating, and forming an intestinal inflammation model.